(Q40954016)

25 September 2017

1 reference

title

Management of suspected neuroleptic malignant syndrome (English)

1 reference

25 September 2017

Velamoor VR

1

1 reference

25 September 2017

Swamy GN

2

1 reference

25 September 2017

Parmar RS

3

1 reference

25 September 2017

Williamson P

4

1 reference

25 September 2017

Caroff SN

5

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 November 1995

1 reference

Canadian Journal of Psychiatry

25 September 2017

published in

1 reference

25 September 2017

volume

40

1 reference

25 September 2017

issue

9

1 reference

25 September 2017

page(s)

545-550

1 reference

A rapidly progressing lethal case of neuroleptic malignant syndrome

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F070674379504000907

Frequency and presentation of neuroleptic malignant syndrome: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379504000907

Catatonia and the neuroleptic malignant syndrome--a single entity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379504000907

The neuroleptic malignant syndrome: agent and host interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379504000907

Neuroleptic malignant syndrome: review and analysis of 115 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379504000907

Neuroleptic malignant syndrome: Results of a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379504000907

Neuroleptic catatonia and its relationship to psychogenic catatonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379504000907

Neuroleptic-induced extrapyramidal symptoms with fever. Heterogeneity of the 'neuroleptic malignant syndrome'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379504000907

Distinguishing neuroleptic malignant syndrome (NMS) from NMS-like acute medical illnesses: a study of 34 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379504000907

The Treatment of Neuroleptic Malignant Syndrome are Dantrolene and Bromocriptine Useful Adjuncts to Supportive Care?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379504000907

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379504000907

10.1177/070674379504000907

21 January 2018

Identifiers

DOI

1 reference

25 September 2017

1 reference